Video

Dr. Bailey on Clinical Needs in Pediatric Patients With Bone Sarcoma

Kelly Bailey, MD, PhD, physician, department of Pediatric Hematology/Oncology, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, discusses clinical needs in pediatric patients with bone sarcoma.

Kelly Bailey, MD, PhD, physician, department of Pediatric Hematology/Oncology, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, discusses clinical needs in pediatric patients with bone sarcoma.

There are 3 clinical needs for pediatric patients with bone sarcoma, says Bailey. Physicians need to prevent metastases from occurring, better detect micrometastatic disease before it is visible on PET scans or CT scans, and better treat metastases once they occur.

Progress has been limited in the past 3 decades in pediatric patients with metastatic disease, says Bailey. Therefore, when relapse occurs, they need to be sampled and biopsied because metastatic tumors are not like original tumors. If patients consent, these samples can also be given to the Children’s Oncology Group for further testing.

Although progress has been limited, Bailey states that there are therapeutic opportunities that physicians could explore if they understood what signaling pathways are apparent in those metastatic lesions.

Related Videos
Anna Weiss, MD, associate professor, Department of Surgery, Oncology, associate professor, Cancer Center, University of Rochester Medicine
Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology), professor, pharmacology, deputy director, Yale Cancer Center; chief, Hematology/Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital; assistant dean, Translational Research, Yale School of Medicine
Victor Moreno, MD, PhD
Tiago Biachi, MD, PhD
Dr Girard on De Novo and Acquired Resistance Alterations in HER2-Altered NSCLC
Elias Jabbour, MD
Daniel DeAngelo, MD, PhD
Douglas W. Sborov, MD, MS
Meletios (Thanos) Dimopoulos, MD, professor, therapeutics, Hematology Oncology, National and Kapodistrian University of Athens School of Medicine
Adam E. Singer, MD, PhD, Health Sciences Clinical Instructor, medicine, division lead, kidney cancer, Division of Hematology/Oncology, UCLA Health